CHARACTERIZATION OF UDP-GLUCURONOSYLTRANSFERASES(UGTS)INVOLVED IN THE METABOLISM OF TROGLITAZONE IN RATS AND HUMANS

スポンサーリンク

概要

• 論文の詳細を見る

• UDP-glucuronosyltransferases(UGTs)involved in troglitazone glucuronidation in rats and humans have been characterized to support the previous toxicity study on troglitazone in Gunn rats and to examine whether the UGT polymorphism or inhibition of bilirubin metabolism is related to the clinically reported rare cases of liver failure. The experiments using Gunn rats revealed that UGT1 enzymes are not involved in troglitazone glucuronidation and that the responsible enzyme in rats was suggested to be UGT2B2, an androsterone UGT, by inhibition sudies. In humans, contribution of UGT1A1 was estimated to be about 30% of the total troglitazone glucuronidation by UGTs, using human liver microsomes and recombinant UGTs. Other UGT1 and UGT2 enzymes seem to be responsible for the rest of the troglitazone glucuronidation in humans. The multiplicity of UGTs involved in troglitazone glucuronidation in humans may allow even patients lacking bilirubin UGT(UGT1A1)activity to produce troglitazone glucuronide. These observations suggest that the polymorphism of UGT is not the reason behind the liver failure induced by the troglitazone treatment, and troglitazone does not inhibit bilirubin glucuronidation in clinical treatment. In addition, the increased bilirubin level in the blood of patients who have troglitazone-induced liver failure is a consequence of liver injury and not due to inhibition of bilirubin glucuronidation by troglitazone.

• 日本トキシコロジー学会の論文
• 2000-12-25

著者

• IKEDA Toshihiko

  Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd.

• Takasaki Wataru

  Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.

• Ikeda Toshihiko

  Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.

• Konno Kumiko

  Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd.

• YOSHIGAE Yasushi

  Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd

• Yoshigae Yasushi

  Drug Metabolism And Pharmacokinetics Research Laboratories Sankyo Co. Ltd

関連論文

• Structure Elucidation of Novel Metabolites of Gemfibrozil in Dog : Conjugation Reaction of Conjugated Metabolites
• Novel Organic Nitrate Prodrug 4(R)-N-(2-Nitroxyethyl)-2-Oxothiazolidine-4-Carboxamide (RS-7897) Serves as a Xenobiotic Substrate for Pyroglutamyl Aminopeptidase I in Dogs
• Identification of Gemfibrozil Metabolites, Produced as Positional Isomers in Human Liver Microsomes, by On-line Analyses Using Liquid Chromatography/Mass Spectrometry and Liquid Chromatography/Nuclear Magnetic Resonance Spectroscopy
• CHARACTERIZATION OF UDP-GLUCURONOSYLTRANSFERASES(UGTS)INVOLVED IN THE METABOLISM OF TROGLITAZONE IN RATS AND HUMANS
• A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells
• 各種ARBのCYP2C9に対する親和性の比較
• Characterization of CS-023 (RO4908463), a Novel Parenteral Carbapenem Antibiotic, and Meropenem as Substrates of Human Renal Transporters

スポンサーリンク